{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:44:32Z","timestamp":1792154672802,"version":"4.4.0"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jhep.2026.09.022","type":"journal-article","created":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:07:08Z","timestamp":1791040028000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["SETDB1: An epigenetic gatekeeper of antitumor immune organization in HCC"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6776-1635","authenticated-orcid":false,"given":"Pauline","family":"Hamon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2026.09.022_bib1","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/s41586-019-1914-8","article-title":"Tertiary lymphoid structures improve immunotherapy and survival in melanoma","volume":"577","author":"Cabrita","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2026.09.022_bib2","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1038\/s41590-024-01992-w","article-title":"Immunotherapy response induces divergent tertiary lymphoid structure morphologies in hepatocellular carcinoma","volume":"25","author":"Shu","year":"2024","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jhep.2026.09.022_bib3","doi-asserted-by":"crossref","DOI":"10.1126\/science.ady1678","article-title":"Dendritic cells control tertiary lymphoid structure development and maintenance in cancer","volume":"393","author":"Mattiuz","year":"2026","journal-title":"Science"},{"key":"10.1016\/j.jhep.2026.09.022_bib4","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1038\/s41591-023-02345-0","article-title":"Intratumoral dendritic cell\u2013CD4+ T helper cell niches enable CD8+ T cell differentiation following PD-1 blockade in hepatocellular carcinoma","volume":"29","author":"Magen","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2026.09.022_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2026.07.002","article-title":"CCR7+ activated dendritic cells are essential for spontaneous and immunotherapy-driven anti-tumor immunity","author":"Koufaki","year":"2026","journal-title":"Immunity"},{"key":"10.1016\/j.jhep.2026.09.022_bib6","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/j.ccell.2024.09.007","article-title":"The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions","volume":"42","author":"MacFawn","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jhep.2026.09.022_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2026.07.007","article-title":"Setdb1 represses anti-tumor immunity and tertiary lymphoid structures in hepatocellular carcinoma","author":"Shen","year":"2026","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.09.022_bib8","doi-asserted-by":"crossref","first-page":"596","DOI":"10.3390\/v12060596","article-title":"SETDB1-Mediated silencing of retroelements","volume":"12","author":"Fukuda","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.jhep.2026.09.022_bib9","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/s41556-018-0261-6","article-title":"AKT methylation by SETDB1 promotes AKT kinase activity and oncogenic functions","volume":"21","author":"Guo","year":"2019","journal-title":"Nat Cel Biol"},{"key":"10.1016\/j.jhep.2026.09.022_bib10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41586-021-03520-4","article-title":"Epigenetic silencing by SETDB1 suppresses tumour intrinsic immunogenicity","volume":"595","author":"Griffin","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2026.09.022_bib11","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s13402-025-01157-3","article-title":"The epigenetic regulator SETDB1 as a key component of cancer stem cells and drug resistance in primary liver cancer","volume":"49","author":"Padelli","year":"2026","journal-title":"Cell Oncol"},{"key":"10.1016\/j.jhep.2026.09.022_bib12","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1158\/2326-6066.CIR-23-0514","article-title":"Setdb1 loss induces Type I interferons and immune Clearance of melanoma","volume":"13","author":"McGeary","year":"2025","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.jhep.2026.09.022_bib13","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41586-021-03994-2","article-title":"KDM5B promotes immune evasion by recruiting SETDB1 to silence retroelements","volume":"598","author":"Zhang","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2026.09.022_bib14","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1038\/s41467-025-57005-3","article-title":"Potent and selective SETDB1 covalent negative allosteric modulator reduces methyltransferase activity in cells","volume":"16","author":"Uguen","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2026.09.022_bib15","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1158\/2159-8290.CD-19-0074","article-title":"\u03b2-Catenin activation promotes immune Escape and resistance to anti\u2013PD-1 therapy in hepatocellular carcinoma","volume":"9","author":"Galarreta","year":"2019","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jhep.2026.09.022_bib16","doi-asserted-by":"crossref","DOI":"10.1126\/science.adz2742","article-title":"Pan-cancer spatial atlas of tertiary lymphoid structures","volume":"392","author":"Cho","year":"2026","journal-title":"Science"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827826029168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827826029168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T11:47:33Z","timestamp":1792151253000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827826029168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":16,"alternative-id":["S0168827826029168"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2026.09.022","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SETDB1: An epigenetic gatekeeper of antitumor immune organization in HCC","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2026.09.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2026.07.007","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Association for the Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}